United States · FDA National Drug Code directory
terbinafine hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 71335-9677_ebbb6769-54f5-415e-a685-0c6baf35645d
- Product NDC
- 71335-9677
- Form
- TABLET
- Composition / generic term
- terbinafine hydrochloride
- Labeler
- Bryant Ranch Prepack
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20220128
- Source listing expiry
- 20261231
Source-listed ingredients
- TERBINAFINE HYDROCHLORIDE — 250 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET in 1 BOTTLE, PLASTIC (71335-9677-1) · 71335-9677-1
- 60 TABLET in 1 BOTTLE, PLASTIC (71335-9677-2) · 71335-9677-2
- 90 TABLET in 1 BOTTLE, PLASTIC (71335-9677-3) · 71335-9677-3
- 100 TABLET in 1 BOTTLE, PLASTIC (71335-9677-4) · 71335-9677-4
- 7 TABLET in 1 BOTTLE, PLASTIC (71335-9677-5) · 71335-9677-5
- 40 TABLET in 1 BOTTLE, PLASTIC (71335-9677-6) · 71335-9677-6
- 45 TABLET in 1 BOTTLE, PLASTIC (71335-9677-7) · 71335-9677-7
- 14 TABLET in 1 BOTTLE, PLASTIC (71335-9677-8) · 71335-9677-8
- 28 TABLET in 1 BOTTLE, PLASTIC (71335-9677-9) · 71335-9677-9
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →